Opsonophagocytic activity against Streptococcus pneumoniae type 19F in allogeneic BMT recipients before and after vaccination with pneumococcal polysaccharide vaccine

Bone Marrow Transplantation

Volumn 27, Issue 2, 2001, Pages 207-211

  Parkkali, T ^a   Vakevainen M ^b   Kayhty H ^b   Ruutu, T ^a   Ruutu, P ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

BMT recipients; Opsonophagocytic activity; Pneumococcal antibodies

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; OPSONIN; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; ENZYME IMMUNOASSAY; HUMAN; IN VITRO STUDY; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SERUM; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADULT; ANTIBODIES, BACTERIAL; BONE MARROW TRANSPLANTATION; HEMATOLOGIC NEOPLASMS; HUMANS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035132192     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702779     Document Type: Article

References (29)

1. Analysis of late infections in 89 long-term survivors of bone marrow transplantation
2. Pneumococcal infections after human bone-marrow transplantation
3. Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation
4. Advances in the management of infectious complications after bone marrow transplantation
5. Life-threatening infections occurring more than 3 months after BMT
6. Fatal pneumococcal infections following allogeneic bone marrow transplantation
7. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study
8. Invasive pneumococcal infection following PBSCT and BMT - And EBMT survey
9. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants
10. Spontaneous pneumococcal peritonitis: Late infection after bone-marrow transplantation
11. Pneumococcal arthritis after allogeneic bone marrow transplantation
12. Pneumococcal vaccination of recipients of bone marrow transplants
13. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine
14. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients
15. Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation
16. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: The influence of graft versus host reaction
17. Polysaccharide conjugate vaccine responses in bone marrow transplant patients
18. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation
19. Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease
20. Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GVHD: Preliminary observations
21. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia
22. Pathogenesis of pneumococcal infection
23. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT
24. Pneumococcal polysaccharide- meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children
25. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S
26. Contribution of sero-type-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae
27. Specific IgG subclass antibody levels and phagocytosis of serotype 14 pneumococcus following immunization
28. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults
29. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults